Altria Group, Inc. research snapshot

MO AI Stock Analysis

MO AI stock analysis currently reads Altria Group, Inc. as a mature U.S. nicotine company with strong pricing power, high cash generation, dividend support, and persistent volume, regulation, and product-transition risk. The analysis uses scenario ranges, not a certain price prediction. At the July 8, 2026 data cutoff, the latest verified close used here was $72.96 on July 7, 2026, with an implied market capitalization of about $121.84 billion. This is informational research and not investment advice.

Current price

$72.96

Market cap

$121.84 billion

AI score

62 / 100

Rating

High cash yield, regulatory decline risk

Trend status

Uptrend above key moving averages

Data cutoff (updated weekly)

July 8, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness
A-level information richness. Altria has decades of public filings, company releases, third-party financial coverage, active technical data, and a well documented regulatory risk profile.
bias Check
The main AI bias risk is consensus anchoring around the dividend and the tobacco decline narrative. This page separates verified cash-flow facts from forward-looking judgments about volume decline, smoke-free products, and regulation.
ai Confidence
High data confidence
investment Certainty
Medium-low. The financial record is well documented, but investment certainty is limited by secular cigarette volume decline, litigation, excise policy, FDA risk, and the need for successful smoke-free growth.

Quick verdict table

DimensionConclusionConfidence
Business qualityAltria sells cigarettes, oral tobacco, nicotine pouches, cigars, and e-vapor products to adult U.S. consumers, with Marlboro still anchoring cash flow.Medium-high
MoatMoat comes from Marlboro brand power, retail distribution, regulation that raises barriers, pricing power, and scale in U.S. tobacco.Medium-high
ManagementSal Mancuso became CEO in 2026 after serving as CFO, so management should be judged by smoke-free execution, capital allocation, leverage discipline, and dividend coverage.Medium
Financial trend2025 revenue declined to $23.279 billion while net income was $6.947 billion; Q1 2026 revenue net of excise taxes grew 5.3%.High
ValuationThe stock trades as a cash-return and dividend compounder, with verified PE near 17.7x and FCF yield near 7.5% at the cutoff price.Medium-high
Technical trendMO closed above the 50-day and 200-day moving averages, but volume was below its 50-day average, so breakout confirmation matters.Medium
Risk levelThe thesis can fail if cigarette volumes fall faster than pricing, FDA rules restrict key products, NJOY or on! disappoint, or litigation and tax pressure rise.High
AI confidenceHigh for historical financials, market-cap math, and risk mapping. Lower for forward share-price outcomes.High data confidence
Investment certaintyMedium-low certainty because durable cash flow is balanced against structural volume decline and regulatory tail risk.Medium-low

MO AI stock forecast

MO AI Stock Forecast Scenarios

The MO AI stock forecast uses three-year scenario ranges around the $72.96 cutoff close. The financial-rigor model produced a bullish value near $83.40, a base value near $65.60, and a bearish value near $41.40 using EPS growth and terminal PE assumptions. These are scenario outputs, not promises.

Bullish case

$79 to $87

More likely if adjusted EPS grows near the top of guidance, Marlboro pricing offsets volume declines, on! and NJOY gain profitable share, and the stock holds above the resistance zone with healthy volume.

Base case

$62 to $70

More likely if Altria keeps cash flow stable but investors apply a lower multiple because cigarette volumes decline and smoke-free growth remains gradual.

Bearish case

$39 to $46

More likely if earnings contract, regulation or litigation damages pricing power, the smoke-free portfolio fails to scale, or the stock loses both the 50-day and 200-day moving averages.

MO AI technical analysis

MO AI Technical Analysis

MO AI technical analysis uses the July 7, 2026 close of $72.96 and public technical snapshots available at the July 8, 2026 data cutoff. The setup was positive but not risk free: price was above the 50-day and 200-day moving averages, while volume was below the 50-day average.

LevelValueWhy it matters
Current price$72.96Latest verified close used for this page, dated July 7, 2026.
Near support$71.00 to $71.02Centered on the 50-day moving average area reported by Barchart and ChartMill.
Deeper support$64.88Approximate 200-day moving average reported by Barchart and ChartMill.
Near resistance$74.56 to $78.00The lower end is the recent 52-week high cited by MarketWatch; the upper end is a planning zone for a confirmed breakout.
50-day moving averageAbout $71.01 to $71.02Public technical snapshots showed MO above a rising 50-day average at the cutoff.
200-day moving averageAbout $64.88Public technical snapshots showed MO above a rising 200-day average at the cutoff.
MomentumPositive but extendedChartMill reported RSI near 62.31, a neutral reading, while moving average signals remained positive.
Volume5.2 million vs 9.0 million averageMarketWatch reported July 7 volume below the 50-day average, so a breakout needs stronger confirmation.
VolatilityModerate defensive equity volatilityDividend yield can reduce perceived volatility, but regulatory headlines can create sharp gaps.
InvalidationClose below $71.00, then $64.88A close below the 50-day average weakens the short-term setup; losing the 200-day average would challenge the longer trend.

MO AI trading strategy

MO AI Trading Strategy Framework

The MO AI trading strategy is a rules-based research framework. It is not personalized advice. Traders should pair the setup with live price data, dividend dates, earnings releases, FDA headlines, position sizing, and predefined invalidation levels.

Trend-following setup

Wait for MO to hold above the $71.00 support area and break the $74.56 resistance area with volume above the recent average.

A failed breakout or close below the 50-day moving average invalidates the short-term setup.

Mean-reversion setup

If MO pulls back toward the 50-day average without a negative filing, litigation, or FDA event, compare the yield, payout coverage, and volume trend before considering a reversion trade.

Do not average down if the pullback is caused by an earnings miss, regulatory change, or faster combustible volume decline.

Fundamental monitor

Track Marlboro retail share, cigarette shipment decline, pricing, on! pouch share, NJOY economics, adjusted EPS guidance, debt, dividend coverage, and repurchase pace.

Reduce confidence when cash returns depend more on multiple expansion than on stable earnings and free cash flow.

Investment research summary

Four-master Research Compression

Business essence

Altria monetizes adult nicotine demand through a dominant U.S. cigarette franchise, oral tobacco, nicotine pouches, cigars, and e-vapor products.

Moat

The moat is strongest in brand, distribution, scale, and regulatory barriers, but it narrows if consumers migrate faster than Altria can build profitable smoke-free platforms.

Munger risk inversion

The failure path is faster cigarette volume decline, tougher FDA or tax policy, litigation shocks, poor smoke-free economics, and capital returns that mask eroding business quality.

Management

The CEO transition to Sal Mancuso makes capital allocation, leverage discipline, dividend coverage, and smoke-free execution the key scorecard.

Industry trend

Nicotine demand is durable, but combustible tobacco is in structural decline. The long-term trend depends on whether Altria can shift profit pools without losing pricing power.

Valuation and margin of safety

At $72.96, the stock requires stable cash flow, modest EPS growth, and continuing capital returns. The margin of safety is weaker if investors demand a lower PE for regulatory and volume risk.

Source-backed data

MO Data Table

Every metric below includes a source and last verification date.

MetricValueSourceLast verified
MO closing price$72.96 on July 7, 2026Yahoo Finance historical price snapshotJuly 8, 2026
Market capitalization$121.84 billion, verified as $72.96 x 1.67 billion sharesfinancial_rigor.py market-cap verificationJuly 8, 2026
2025 net revenues$23.279 billion, down 3.1%Altria FY2025 results and SEC companyfactsJuly 8, 2026
2025 net income$6.947 billionSEC companyfacts cross-checked with third-party summariesJuly 8, 2026
2025 cash and long-term debt$4.474 billion cash and $25.709 billion long-term debtSEC companyfactsJuly 8, 2026
2025 diluted EPS$4.12 reported diluted EPS and $5.42 adjusted EPS baseSEC companyfacts and Altria FY2025 resultsJuly 8, 2026
2026 Q1 updateQ1 2026 net revenues were $5.428 billion and revenue net of excise taxes rose 5.3%Altria Q1 2026 resultsJuly 8, 2026
2026 adjusted EPS guidance$5.56 to $5.72Altria Q1 2026 resultsJuly 8, 2026
Technical moving averages50-day about $71.01 to $71.02; 200-day about $64.88Barchart and ChartMill technical snapshotsJuly 8, 2026
Volume and 52-week high contextJuly 7 volume was 5.2 million shares; 52-week high was $74.56MarketWatch July 7, 2026 market data storyJuly 8, 2026
LeadershipSal Mancuso is Chief Executive OfficerAltria leadership profile and CEO transition releaseJuly 8, 2026

Frequently Asked Questions

This MO AI stock analysis page is an informational tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available data as of July 8, 2026, may be incomplete, and can be wrong if new filings, market prices, FDA actions, litigation, dividend policy, or macro conditions change.